Project Grant HT94252410264
Award Date
9/1/24
Completion Date
8/31/27
Dollars Obligated
$1.4M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Salt Lake City, UT 84112, USA
Similar Awards
The University of Utah will receive $1,142,061 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420) to undertake the project "Modulation of T-Cell Receptor-Mediated Intratumoral Antigen Recognition" from September 1, 2022 through August 31, 2025. This funding will support research aimed at transforming health care for service members and the public through innovative and impactful medical solutions...
The University of Utah has been awarded a $1,128,787 Project Grant by the Defense Health Agency, an agency of the U.S. Department of Defense, under the Military Medical Research and Development program (CFDA 12.420). The grant is for a 3-year project titled "OPTIMIZING QUANTITATIVE PHASE IMAGING FOR PREDICTING BREAST CANCER THERAPY RESPONSE," with a performance period from January 15, 2024 to January 14, 2027. The funded research aims to develop and evaluate advanced quantitative phase...
The University of Utah will receive $6,079,790 under a four-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research from July 2022 to June 2026 to develop functional precision oncology approaches to predict, prevent, and treat early metastatic recurrence of triple-negative breast cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical...
The University of Utah will receive $3.56 million through a four-year cooperative agreement award from the Department of the Army Medical Command under the Military Medical Research and Development program. The university will work to prevent lethal metastatic breast cancer by identifying and eradicating clinically relevant disseminated tumor cells. The award period runs from August 1, 2022 through July 31, 2026 with performance taking place in Salt Lake City, Utah. Through this funding, the...
The University of Utah has been awarded a $824,512 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from June 1, 2024 to May 31, 2027, will fund research on "Digital Pathology Predictions of Treatment Response in Hormone-Sensitive Prostate Cancer." This project aims to leverage digital pathology techniques to improve the prediction of treatment outcomes for patients with hormone-sensitive...
This federal Project Grant award of $462,000.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, will support the University of Utah's research project titled "ADVANCING RISK PREDICTION AND PREVENTION TO MITIGATE THE BURDEN OF CARDIOVASCULAR DISEASE IN MEN WITH PROSTATE CANCER." The award, with a performance period from Sep 15, 2024 to Sep 14, 2026, will fund advanced biomedical research initiatives...
The University of Utah has been awarded a $654,105 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Digital Pathology Predictions of Treatment Response in Hormone-Sensitive Prostate Cancer." The three-year grant, awarded on June 1, 2024, will support the university's cutting-edge research aimed at improving health outcomes for military service members, veterans, and the broader public. The...
The University of Utah will receive $1.9 million from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to combat multidrug-resistant urinary tract infections in spinal cord injury patients. From September 1, 2022 through August 31, 2025, the University will conduct research to develop medical solutions for multidrug-resistant urinary tract infections that commonly affect individuals with spinal cord injuries, as part of the...
The University of Utah will receive $1.3 million under a four-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research from July 2022 to June 2026 to develop functional precision oncology approaches to predict, prevent, and treat early metastatic recurrence of triple-negative breast cancer. Through basic, applied, and advanced biomedical research, the Military Medical Research and Development...
This $746,410 Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to the University of Utah supports research to investigate "Tissue Softening as a Biomarker of Traumatic Brain Injury." The award, effective from August 15, 2024 to August 14, 2027, will enable the university to conduct cutting-edge biomedical research aimed at developing improved diagnostic and treatment approaches for traumatic brain injury, a critical health...